Tag Archives: GWPH

Despite Losing $88 Million in Q2, This Pot Stock Still Has More Cash Than Any of Its Peers

The marijuana industry may be growing at an exceptionally fast pace, but that doesn’t mean it’s exempt from challenges. Chief among those challenges for marijuana stocks is securing the capital needed to build their businesses.

You see, most pot companiesdon’t have access to basic banking servicessuch as lines of credit, loans, or even something as simple as a checking account.....More>>>

Therapix Biosciences Gets A Buy Rating From Laidlaw Analyst

Therapix Biosciences (NASDAQ:TRPX) received an initiation of coverage from Laidlaw & Company analyst Francois Brisebois who gave the company a Buy rating and a $18.00 price target. Therapix’s lead drug is an FDA approved dronabinol, which is a biosynthetic form of THC. The company’s strategy is to repurpose, reposition and improve the FDA approved cannabinoid for various....More>>>

661 Million Reasons to Like These 3 Marijuana Stocks”

Why should investors like marijuana stocks? For some, the rationale might be the enormous market potential. For others, it could be simply that many marijuana stocks have soared over the last year or so.

There are plenty of reasons for investors to like three marijuana stocks in particular — GW Pharmaceuticals (NASDAQ:GWPH), Insys Therapeutics (NASDAQ:INSY), and Aphria (NASDAQOTH:APHQF).....More>>>

Despite Legislative Uncertainty In US, Pharmaceutical’s Cannabis Developments Show Promise For Inv

Once upon a not-so-long-ago time, the legal cannabis industry was a regular Wild West for investors looking to get in early on a brand new sector. Issues of ambiguous if not downright contradictory legislation in the US and challenges to interfacing with the American banking system served as sizeable deterrents for larger institutional investors, leaving the myriad new opportunities to....More>>>

Will Falling Cannabis Prices Hurt Marijuana Stocks?”

Cannabis prices are going to pot.

As increasingly more marijuana growers entered the market and more states allowed residents to legally grow marijuana, cannabis prices dropped throughout 2016. Wholesale marijuana prices late in the year were roughly half the levels of 12 months earlier. Will this trend continue — and possibly hurt leading marijuana stocks including Aphria....More>>>

Is This Hot Marijuana Stock Too Expensive to Buy?”

In just 12 months, shares of GW Pharmaceuticals (NASDAQ:GWPH) have shot up 125%. Over the past five years, the market cap of the cannabinoid-focused biotech has increased by well over 1,100%. Is GW Pharmaceuticals still a good pick for investors — or is this hot marijuana stock just too expensive to buy right now?

Image source: Getty Images.

Over-hyped?

Some....More>>>

Is This Hot Marijuana Stock Too Expensive to Buy?”

In just 12 months, shares of GW Pharmaceuticals (NASDAQ:GWPH) have shot up 125%. Over the past five years, the market cap of the cannabinoid-focused biotech has increased by well over 1,100%. Is GW Pharmaceuticals still a good pick for investors — or is this hot marijuana stock just too expensive to buy right now?

Image source: Getty Images.

Over-hyped?

Some....More>>>